Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes

Documenti analoghi

• Gastric bypass elicits persistent gut adaptation and unique diabetes remission‐related metabolic gene regulation
  di: Margaret A. Stefater‐Richards, et al.
  Pubblicazione: (2024)
• Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction‐associated steatotic liver disease
  di: Carmen Arto, et al.
  Pubblicazione: (2024)
• LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease
  di: Yong Wen Leow, et al.
  Pubblicazione: (2024)
• Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary
  di: Leon A Adams, et al.
  Pubblicazione: (2025)
• Ability of triglyceride‐glucose indices to predict metabolic dysfunction associated with steatotic liver disease in pediatric obesity
  di: Procolo Di Bonito, et al.
  Pubblicazione: (2025)